Byline: Kiplinger Washington Editors Johnson & Johnson (JNJ) held a meeting with Wall Street analysts on Thursday to discuss its pharmaceutical pipeline. It was the first detailed review of the pipeline in four years, and news of several potential new drugs has made analysts at some investment ... (Publication: Kiplinger's Pick of the Day Web Feature)
↧